home · filing · 0001493152-22-000042
8-K
filed January 3, 2022, 6:59 PM ET
ticker XTNT
CIK 0001453593
leadership
confidence high
sentiment neutral
materiality 0.50
Xtant Medical appoints Scott Neils as interim CFO; Greg Jensen departs effective Jan 3, 2022
Xtant Medical Holdings, Inc.
Greg Jensen, VP Finance and CFO, terminated effective January 3, 2022.
Scott Neils, previously Controller since August 2019, appointed Interim CFO.
Neils receives $300,000 base salary, 35% target bonus, 109,164 options and 88,983 RSUs.
Jensen expected to enter standard separation agreement with severance per employment contract.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2022-01-03
Filed January 3, 2022, 6:59 PM ET
announced the appointment of Scott Neils as Interim Chief Financial Officer
Departed
Greg Jensen
Vice President, Finance and Chief Financial Officer
XTNT ·
Xtant Medical Holdings, Inc.
Effective 2022-01-03
Successor Scott Neils
Filed January 3, 2022, 6:59 PM ET
whose employment terminated effective as of January 3, 2022.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Scott Neils was appointed as Interim Chief Financial Officer at Xtant Medical Holdings, Inc..
Action appointed
Role Interim Chief Financial Officer
Exact text from the filing
announced the appointment of Scott Neils as Interim Chief Financial Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Greg Jensen was terminated as Vice President, Finance and Chief Financial Officer at Xtant Medical Holdings, Inc..
Action terminated
Role Vice President, Finance and Chief Financial Officer
Exact text from the filing
whose employment terminated effective as of January 3, 2022.
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-22-000042
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.